Abstract

PRE-EXCITATION SYNDROME/ Wolff-Parkinson-White (WPW) SYNDROME: OVERVIEW

Dr. Renoy Philip*, Minu Mathew and Jemi Elza

ABSTRACT

First described by Louis Wolff, John Parkinson and Paul Dudley White in 1930. It is a grouping of the existence of a congenital accessory pathway and episodes of tachyarrhythmia. Incidence 0.1 – 3.0 per 1000. Allied with a small risk of sudden cardiac death. It is a treatable circumstance and also referred to as pre-excitation syndrome. It can involve all ages but is typically diagnosed in children, adolescents and young adults. Experience episodes of heart suddenly starts racing, before stopping or slowing down abruptly. These episodes can end for seconds, minutes or hours. The diagnosis of WPW syndrome is normally made with a 12-lead electrocardiogram and occasionally with ambulatory monitoring. The key of thought is based on the history and seldom physical examination. Treatment depends on the nature and occurrence of arrhythmias, allied symptoms (syncope) and existence of structural heart disease. People with WPW who are experiencing tachy-dysrhythmias may necessitate synchronized electrical cardio version if they are representing severe signs or symptoms (low blood pressure or lethargy with distorted mental status). If they are comparatively stable, pharmacologic treatment may be used. Patients who present in cardiac arrest or with hemodynamic conciliation necessitate management of the ABCs (Airway, Breathing and Circulation), as is regular and includes having a defibrillator existing and providing proper monitoring. Once the patient is determined to be experiencing a dysrhythmia, direct-current (DC) cardio version is indicated. Wolff-Parkinson-White syndrome cannot be revented, but can be treated in the vast majority of people.

Keywords: Congenital accessory pathway, pre-excitation syndrome, Supraventricular tachycardia, tachyarrhythmia, tachy-dysrhythmias, Wolff-Parkinson-White (WPW) syndrome.